Small observational studies and patient reports suggest that some individuals starting GLP1 therapy for diabetes or obesity have experienced: Fewer asthma exacerbations Reduced use of rescue inhalers Better lung function One possible explanation is that weight loss and metabolic improvements also reduce inflammation throughout the body, including the lungs
Contact your GP if you experience persistent or worsening heartburn despite lifestyle changes, difficulty swallowing, unintentional weight loss, signs of gastrointestinal bleeding, or severe abdominal pain
These risks may not be deal breakers for most people, and its very likely that retatrutide will be approved by the FDA within the next few years, says DeCotiis
associated with heart disease
Some patients found WeightWatchers too restrictive, noting they could run out of points quickly while still overeating free foods, making it hard to sustain
AlixPartners research found that 85% of consumers buying holistic beauty products want detailed ingredient information